CENTOGENE Announces Voting Results of Extraordinary General Meeting
CENTOGENE Announces Voting Results of Extraordinary General Meeting CENTOGENE Announces Voting Results of Extraordinary General Meeting CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 18, 2020 — Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, today announced the voting results of the Company’s Extraordinary General Meeting. The shareholders of the Company voted in favor of al...